Charles R M Hay

15PUBLICATIONS
34CO-AUTHORS
Epidemiological modellingHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cardiovascular medicine and haematology not elsewhere classifiedSocial robotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 29, 2023
Association of patient, treatment and disease characteristics with patient-reported outcomes: Results of the ECHO Registry.

Charles R M Hay, Michael Makris, Midori Shima

|Feb 22, 2023
Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO).

Caroline Wall, Hua Xiang, Ben Palmer

|May 09, 2022
The bleeding phenotype in people with nonsevere hemophilia.

Fabienne R Kloosterman, Anne-Fleur Zwagemaker, Catherine N Bagot

|Aug 17, 2021
Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.

Daniel P Hart, Jayanthi Alamelu, Neha Bhatnagar

|Oct 23, 2020
Challenges and key lessons from the design and implementation of an international haemophilia registry supported by a pharmaceutical company.

Charles R M Hay, Midori Shima, Michael Makris

|May 09, 2019
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.

Peter Volkers, Kay-Martin Hanschmann, Thierry Calvez

Pageof 3